Medicated Pain Relief Patches

Description

This product is distributed by Meijer Distribution, Inc., located in Grand Rapids, MI 49544. It is packaged in a box containing 60 units. The product should be stored in a clean, dry place, away from direct sunlight, and protected from excessive moisture to maintain its integrity.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children 12 years of age and over should begin by cleaning and drying the affected area thoroughly. The patch should then be removed from its protective film and applied directly to the affected area. It is recommended that the patch be applied no more than 3 to 4 times daily. Each patch should be removed from the skin after a maximum application duration of 8 hours.

For children under 12 years of age, it is advised to consult a physician prior to use to determine appropriate treatment and dosage.

Contraindications

The product is contraindicated in the following situations:

Use is not recommended on wounds or damaged skin due to the potential for irritation and adverse effects. The application of a heating pad concurrently is contraindicated, as it may increase the risk of burns or skin damage.

Patients with known allergies to any ingredients in this product should avoid its use to prevent allergic reactions. Additionally, contact with eyes, mucous membranes, or rashes must be avoided to prevent irritation.

Tight bandaging is contraindicated, as it may restrict circulation and exacerbate local reactions. The simultaneous use of other topical analgesics is also contraindicated to avoid potential interactions and increased risk of side effects.

Warnings and Precautions

Patients with a known allergy to aspirin or salicylates should consult a healthcare professional prior to use to mitigate the risk of an allergic reaction.

In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Healthcare providers should advise patients to discontinue use and seek medical attention if any of the following occur: the development of a rash, itching, or excessive skin irritation; worsening of the condition; or if symptoms persist beyond 7 days or resolve only to recur within a few days.

Side Effects

Patients should be aware of potential adverse reactions associated with the use of this medication. Individuals with a known allergy to aspirin or salicylates are advised to consult a healthcare professional prior to use to mitigate the risk of an allergic reaction.

In clinical practice, patients are instructed to discontinue use and seek medical advice if they experience any of the following symptoms: rash, itching, or excessive skin irritation. Additionally, if the condition being treated worsens or if symptoms persist for more than 7 days, or if symptoms resolve and then recur within a few days, it is essential to consult a healthcare provider for further evaluation and management.

Drug Interactions

Concurrent use of this medication with other topical analgesics is contraindicated. The combination may increase the risk of adverse effects without providing additional therapeutic benefit. It is advised to avoid using multiple topical analgesics simultaneously to ensure patient safety and efficacy of treatment. Monitoring for any signs of irritation or adverse reactions is recommended if there is a need to switch to or from another topical analgesic.

Packaging & NDC

Below are the non-prescription pack sizes of Medicated Pain Relief Patches (camphor, menthol, methyl salicylate). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should be treated with caution, and consultation with a physician is recommended prior to use. It is essential to keep the product out of reach of children, as used patches still contain the drug and can pose serious risks if ingested or chewed by children or pets. In the event of accidental ingestion, immediate medical assistance or contact with a Poison Control Center is advised.

For adolescents aged 12 years and older, the recommended application involves cleaning and drying the affected area before applying the patch. The patch should be removed from its film and applied to the affected area no more than 3 to 4 times daily, with a maximum application duration of 8 hours per patch. Proper disposal of used patches is crucial to prevent accidental exposure to children and pets.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy.

Pregnancy

The safety of this product during pregnancy has not been established. This product is contraindicated in pregnancy due to potential risks to the fetus. Pregnant patients or those planning to become pregnant should consult a healthcare provider before use to discuss potential risks and benefits.

Lactation

Lactating mothers should consult a doctor before using this product. There is a potential for excretion in breast milk, and the safety of this product during lactation has not been established. Caution is advised when using this product while breastfeeding.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of information necessitates careful clinical judgment and monitoring.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor patients closely for any signs or symptoms that may arise following an overdose. Common symptoms may include, but are not limited to, altered mental status, cardiovascular instability, and gastrointestinal disturbances.

In the event of an overdose, immediate medical attention should be sought. Supportive care is the cornerstone of management, which may involve maintaining airway patency, providing supplemental oxygen, and ensuring hemodynamic stability.

Healthcare professionals should also consider contacting a poison control center for guidance on specific interventions and treatment protocols tailored to the substance involved in the overdose.

Documentation of the incident, including the amount and timing of the substance taken, is crucial for effective management and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

Postmarketing experience has identified the potential for serious adverse effects in cases where a child or pet chews or ingests a used patch, as these patches may still contain the drug product. This information has been reported voluntarily and through surveillance programs, highlighting the importance of proper disposal and storage of used patches to mitigate risks.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important to instruct patients not to apply the product on wounds or damaged skin, and to avoid using it in conjunction with a heating pad.

Patients should be informed that they must not use the product if they have a known allergy to any of its ingredients. They should be counseled to discontinue use and consult a doctor if they experience rash, itching, or excessive skin irritation. Additionally, patients should be advised to stop using the product and seek medical advice if their condition worsens, if symptoms persist for more than 7 days, or if symptoms resolve and then recur within a few days.

Healthcare providers should emphasize the importance of using the product only as directed and to avoid contact with eyes, mucous membranes, or rashes. Patients should be instructed not to bandage the area tightly and to refrain from using the product simultaneously with other topical analgesics.

Finally, it is crucial to inform patients about the safe disposal of used patches, ensuring they are kept out of reach of children and pets, as these patches may still contain active drug that could lead to serious adverse effects if ingested.

Storage and Handling

The product is supplied in a clean, dry package designed to protect it from direct sunlight and excessive moisture. It is essential to store the product in a location that maintains these conditions to ensure its integrity and effectiveness.

After use, the patch must be disposed of properly to prevent access by children and pets, ensuring safety in the environment.

Additional Clinical Information

Patients should be advised that the medication is administered topically. For adults and children aged 12 years and older, the affected area should be cleaned and dried before applying the patch, which can be used no more than 3 to 4 times daily. Each patch should be removed after a maximum of 8 hours. For children under 12 years of age, consultation with a physician is recommended prior to use.

Clinicians should counsel patients on potential allergic reactions, particularly for those with a history of allergies to aspirin or salicylates. It is important to instruct patients to dispose of used patches safely, keeping them out of reach of children and pets, as they may still contain active drug that could lead to serious adverse effects if ingested. Patients should discontinue use and seek medical advice if they experience rash, itching, excessive skin irritation, worsening of their condition, or if symptoms persist beyond 7 days or recur shortly after resolution. Additionally, patients should be reminded to keep the product out of reach of children and to seek immediate medical assistance or contact a Poison Control Center if the patch is swallowed.

Drug Information (PDF)

This file contains official product information for Medicated Pain Relief Patches, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)